Characteristics and outcome of patients with Philadelphia chromosome negative, <i>bcr</i>/<i>abl</i> negative chronic myelogenous leukemia

Francesco Onida, Greg Ball, Hagop M. Kantarjian, Terry L. Smith, Armand B. Glassman, Maher Albitar, Barbara Scappini, Mary Beth Rios, Michael J. Keating, Miloslav Beran

Cancer · 2002 · 99 citations · 73 references

DOIFull text

Open access

Abstract

Bcr/abl negative CML is a distinct clinical entity associated with very poor prognosis. Two risk categories are identifiable using a simple scoring system based on age, hemoglobin level, and leukocyte number.

References

73